Apoplus Station

What Apoplus Station does

Apoplus Station (アポプラスステーション株式会社) is a Japanese contract services company operating two integrated divisions serving the pharmaceutical, medical device, and food/health industries. Its CSO (Contract Sales Organization) division dispatches and manages more than 600 Medical Representatives (MRs) and recruits over 100 MRs annually, with a proprietary training curriculum (APS COLLEGE) and ongoing skill program (APS SKILL CAMP) producing specialized MRs in oncology, immune-related diseases, and central nervous system areas. The CRO (Contract Research Organization) division delivers pharmaceutical and food clinical trial services spanning protocol design, monitoring, statistical analysis, and academic publication, with operational scale ranging from 10-subject to 2,000-subject trials built over more than 20 years.

Underlying technology includes EDC (Electronic Data Capture) and ePRO systems, SAS/SPSS statistical platforms, and CDISC-compliant data standards; the November 2025 acquisition of Clin-Cloud Corporation extended this into an integrated e-Clinical Solutions environment. The company also operates specialized recruitment platforms (MR-PLUS.COM, CRA-recruit.com, and the food-focused ヒト試験サービス) that serve as both demand-generation funnels and candidate pipelines. Revenue is generated through professional-services fees — contract MR staffing, dispatched CRA placement, and project-based CRO engagements — with quote-based pricing rather than published rates.

The business model is essentially B2B enterprise staffing plus outsourced clinical research, sold primarily through direct field sales to pharmaceutical and medical-device manufacturers, supplemented by participation in industry exhibitions (INTERPHEX Week Tokyo, Food Development Expo, healthTECH JAPAN). The company is a wholly-owned subsidiary of QOL Holdings Co., Ltd., part of a broader group spanning pharmaceutical wholesale, retail pharmacy, and healthcare services. Operations are domestic to Japan across Kanto (Tokyo HQ), Kansai (Osaka), and Hokkaido (Sapporo), with approximately 832-872 employees as of 2025-2026.

Name

Apoplus Station

Legal name

アポプラスステーション株式会社

Website

https://apoplus.co.jp

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Apoplus Station is a Japanese CSO and CRO providing contract Medical Representative staffing, CRA dispatch, and clinical trial services to pharmaceutical, medical device, food, and healthcare companies across Japan, wholly owned by QOL Holdings.

Ownership category

akta.pro rank

Product category

Healthcare staffing and clinical research services (CSO/CRO)

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Electronic Data Capture (EDC) Platforms (HLACAOAA)

Keywords

• Contract medical representative staffing
• Clinical research organization services
• CRA dispatch services
• Pharmaceutical sales outsourcing
• Food clinical trial support

Headquarters

HQ city

Chuo

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. CSO - Contract MR Staffing Services: Contract Medical Representative (MR) placement and dispatch services to pharmaceutical and medical device companies. Revenue generated through staffing fees and service contracts with client companies. The company has 600+ MRs on staff and dispatches professionals for sales, marketing, and training support.
2. CRO - Clinical Trial Support Services: Full-service clinical research organization providing food and pharmaceutical clinical trial support. Services range from protocol design, monitoring, secretariat support, statistical analysis to academic presentation. Revenue from project-based service fees for clinical trials.
3. CRA Staffing/Dispatch Services: Placement of Clinical Research Associates (CRAs) and quality managers to pharmaceutical companies and CROs. The company reports that over 70% of its CRAs have 5+ years of experience. Revenue through staffing service fees.
4. MR Training and Education: MR education and certification training programs including APS COLLEGE curriculum. Training is provided to both internal MRs and externally contracted professionals, supporting the company's positioning as a certified MR education provider.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Core offering

APO PLUS STATION provides CSO (Contract Sales Organization) services — contract Medical Representative (MR) staffing, specialized-area MR placement (oncology, immune-related diseases, CNS), and medical IT/device sales staffing — and CRO (Contract Research Organization) services covering pharmaceutical and food clinical trials from protocol design through monitoring, CRA dispatch, statistical analysis, and academic publication. The company supplements these with proprietary MR training curricula (APS COLLEGE, APS SKILL CAMP) and, since November 2025, integrated EDC/ePRO platforms through its ClinCloud subsidiary.

Product overview

APO PLUS STATION operates two core business divisions: CSO (Contract Sales Organization) providing Medical Representative (MR) staffing services, and CRO (Contract Research Organization) offering clinical research and development support for pharmaceuticals and food products. The company maintains three recruitment platforms (MR Plus.com, Human Trial Service, CRA Recruitment Site), internal training programs (APS COLLEGE, APS SKILL CAMP), and a healthcare products subsidiary (APO PLUS HEALTHCARE). Following the November 2025 acquisition of ClinCloud, the company expanded into e-Clinical Solutions. Services span from clinical trial planning, monitoring, statistical analysis, to academic publication support, with specialized MR training in oncology, immune-related diseases, and CNS disorders.

Differentiator

Problem solved

Functional benefit

Products and services

• CSO Business — Contract MR Staffing and Dispatch Contract Sales Organization services for pharmaceutical companies, providing dispatched Medical Representatives (MRs), specialized-area MR placement (oncology, immune-related diseases, CNS), and medical IT/device sales staffing. Targets pharmaceutical and medical device manufacturers seeking flexible, trained sales force on demand.
• CRO Business — Pharmaceutical and Food Clinical Trial Support Contract Research Organization services covering pharmaceutical and food clinical trials end to end — protocol design, monitoring, CRA dispatch, data analysis, statistical analysis, and academic publication support. Serves pharmaceutical, food, and health product companies needing clinical evidence and regulatory documentation.
• Human Trial Service (ヒト試験サービス) — Food Clinical Trial Support Food clinical trial and R&D support service providing comprehensive assistance from test planning and protocol design to data analysis, report writing, and academic publication. Covers areas including body fat, blood glucose, intestinal health, skin, immunity, and cognition for food, beverage, and health product companies.
• Specialized-Area MR Staffing (Oncology, Immune-related, CNS) Dispatch of MRs with proprietary certification in oncology, inflammatory bowel disease / immune-related diseases, and central nervous system therapeutic areas. Trained through the APS COLLEGE curriculum with over 100 specialized MRs produced since 2017. Targets pharmaceutical companies needing high-skill MRs in specialized therapy areas.
• Medical IT/Equipment Sales Staffing Service Staffing service for medical IT and equipment companies providing specialized sales representatives with healthcare knowledge to engage hospitals and clinicians. Leverages the company's two decades of pharmaceutical MR dispatch experience to serve medical device and IT manufacturers.
• CRA Dispatch Service (派遣CRA) Placement of Clinical Research Associates (CRAs) and quality managers to pharmaceutical companies and CROs, with over 70% of dispatched CRAs holding 5+ years of experience. Operates on an external-work assignment model from the Tokyo HQ to client sites, sold through both direct enterprise sales and the cra-recruit.com portal.
• APS COLLEGE — MR Education and Certification Program Proprietary MR training curriculum covering oncology, immune-related diseases, and CNS specialties. Delivered via e-learning, web-based, and classroom programs to develop versatile medical representatives both internally and for external partners. Functions as a feeder for the company's specialized MR dispatch workforce.
• APS SKILL CAMP — Ongoing MR Skill Development Program Continuous skill development training program for MR professionals, launched October 2024 as part of the company's comprehensive MR training ecosystem beyond the initial APS COLLEGE curriculum.
• ClinCloud e-Clinical Solutions Electronic clinical trial environment and solutions integrating EDC (Electronic Data Capture) and ePRO (electronic Patient Reported Outcome) systems. Provides real-time patient-reported outcome data, adverse event tracking, and CDISC-compliant data capture for pharmaceutical and food clinical trials via the subsidiary ClinCloud Co., Ltd.
• MR Plus.com (MRプラスドットコム) — MR Recruitment Platform Recruitment platform for Medical Representatives (MRs) seeking contract MR or career-change positions. Supports experienced professionals and newcomers with training programs and serves as a demand-generation channel connecting corporate CSO clients with qualified MR candidates.
• CRA Recruitment Site (臨床開発モニターの求人募集サイト) Recruitment platform for Clinical Research Associates (CRAs) seeking employment, supporting external-working monitors with smooth onboarding to client sites. Functions as the demand-generation channel for the CRA dispatch business and a corporate client inquiry channel.
• APO PLUS HEALTHCARE Corporation (joint venture) — Healthcare Product Sales Support Joint-venture entity with ZEAL COSMETICS Inc. that develops and sells health support products including nasal mucosal protective devices and probiotic supplements, and provides sales promotion support for dispensing pharmacies. Operated as a subsidiary brand within the APO PLUS STATION group.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• ClinCloud Co., Ltd. (クリンクラウド株式会社)coreTechnology or Integration · 1 November 2025Stock acquisition (100% ownership) completed November 2025. ClinCloud provides e-Clinical Solutions environments integrating EDC/ePRO systems for clinical trials. This acquisition strengthens APO PLUS STATION's digital clinical trial infrastructure.
• APO PLUS HEALTHCARE CorporationcoreStrategic or Co-development Partner · 1 May 2019Joint venture established in May 2019 between APO PLUS STATION CO.,LTD. and ZEAL COSMETICS Inc. to operate health care business. The joint venture develops and sells health support products and provides sales promotion support for dispensing pharmacies.
• QOL Group Companies (クオールグループ関連企業)minorOthersRelated companies include: QOL Co., Ltd. (pharmacy chain), Daiichi Sankyo Espha Co., Ltd. (pharmaceutical), APO PLUS CAREER Co., Ltd. (career services), Medical QOL Co., Ltd. (medical services), SPLENDID Co., Ltd., Fujinaga Pharmaceutical Co., Ltd., QOL ASSIST Co., Ltd. Collaborative synergies across group companies support group-wide healthcare services.
• Nofuku Research Square Association (未病リサーチスクエア協会)minorStrategic or Co-development PartnerPartnership for promoting 'pre-disease' health monitoring. Presented at Food Development Expo 2019 on nationwide medical institution network for product PR and data collection targeting pre-disease individuals.
• Wellness Communications Co., Ltd. (ウェルネス・コミュニケーションズ株式会社)minorStrategic or Co-development PartnerCollaboration partner for pre-disease monitoring initiatives and nationwide medical institution network utilization.
• Medical institutions across Japan (提携医療機関)coreOthersNetwork of medical institutions across Japan for conducting food and pharmaceutical clinical trials. Facilities range from small-scale to large-scale (up to 2,000 subjects) trial capabilities.
• MR Education and Accreditation Center of Japan (公益財団法人MR認定センター)coreImplementation/ SI/ Consulting PartnerCertification body for MR education systems. APO PLUS STATION holds MR-E No.1 (facility certification) and MR-S No.3 (system certification) from this center.
• Japan Pharmaceutical Wholesalers Association (日本保険薬局協会 / NPhA)minorOthersAPO PLUS STATION joined as a supporting member in June 2025, demonstrating commitment to the pharmacy and healthcare industry.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Global CRO providing clinical research, staffing, and laboratory services to pharma and medical device companies. Competes for Japanese pharma clinical trial work and uses similar CRO+CRA-staffing service models to Apoplus Station's CRO division.
• IQVIA Holdings Japan: Global CRO/CSO leader with significant Japan operations offering clinical trial services, real-world evidence, and commercial (sales force) solutions to pharma companies. Competitor in both CRO and CSO segments but with vastly larger scale and a broader international footprint.
• Syneos Health: Global biopharmaceutical solutions organization combining CRO and contract commercial (CSO) services, including MR staffing and sales force solutions. Closely comparable to Apoplus Station's hybrid CSO+CRO offering, although operating at much larger international scale.
• Labcorp Drug Development (formerly Covance): Global CRO offering clinical trial, central lab, and drug development services to pharma. Competes for Japanese and Asia-Pacific pharma trial work and provides similar EDC/clinical data infrastructure to ClinCloud's offerings.

Direct peers

• CMIC Holdings: Japan's largest domestic CRO/CSO, providing pharmaceutical development support, contract MR staffing, and clinical trial services. CMIC is the closest direct peer, operating the same hybrid CSO+CRO model with MR dispatch, site management, and data services in the Japanese pharma market.
• EPS Holdings: Japanese CRO group providing clinical trial services, data management, and MR/CRA staffing for pharma companies. Direct competitor in the Japan CRO and CSO market with comparable full-service offerings including EDC and statistical analysis.

Regional players

• Charles River Laboratories: Global CRO/preclinical research organization with limited but established presence in Japan. Comparable through contract research services for pharma and medical device clients, though focused on preclinical and lab services rather than CSO staffing.

Others

• Suzuken: Japan's largest pharmaceutical wholesaler group, comparable to Apoplus Station's parent QOL Holdings. Tangentially related through the Japanese pharma value chain, especially distribution to pharmacies and clinics that overlap with QOL group's business model.
• Medipal Holdings: Japanese pharmaceutical wholesaler group with CRO and healthcare service subsidiaries. Adjacent through pharma distribution and clinical trial support activities in Japan, providing a partial overlap with Apoplus Station's CRO and QOL group wholesale business.

Emerging players

• World Holdings: Japanese staffing and human resources services group with pharma-focused MR/CRA dispatch and CRO subsidiaries. Comparable through contract MR and CRA staffing services, though more diversified across non-pharma industries.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/APS_CRO_CRA
• LinkedInlinkedin.com/company/apo-plus-station-co-ltd-

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Apoplus Station